Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,584 | 8,354 | 1,671 | 3,537 | 6,250 |
| Marketable Securities | N/A | N/A | 511 | 495 | 463 |
| TOTAL | $5,689 | $8,583 | $2,532 | $4,518 | $6,796 |
| Non-Current Assets | |||||
| PPE Net | 7 | 7 | 6 | 5 | 6 |
| Other Non-Current Assets | 296 | 322 | 347 | 38 | 67 |
| TOTAL | $303 | $328 | $353 | $43 | $73 |
| Total Assets | $5,992 | $8,912 | $2,885 | $4,561 | $6,869 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 860 | 776 | 792 | 997 | 758 |
| Accrued Expenses | 704 | 685 | 383 | 223 | 1,241 |
| TOTAL | $1,564 | $1,461 | $1,175 | $1,434 | $2,119 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 31 | N/A |
| Other Non-Current Liabilities | 184 | 212 | 239 | 0 | 124 |
| TOTAL | $184 | $212 | $239 | $31 | $124 |
| Total Liabilities | $1,748 | $1,673 | $1,414 | $1,465 | $2,243 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16 | 16 | 16 | 9 | 9 |
| Common Shares | 3 | 3 | 3 | 2 | 1 |
| Retained earnings | -278,494 | -275,284 | -271,485 | -269,768 | -246,020 |
| TOTAL | $4,245 | $7,239 | $1,471 | $3,096 | $4,626 |
| Total Liabilities And Equity | $5,992 | $8,912 | $2,885 | $4,561 | $6,869 |